Alexander Yegorov

Mr. Alexander Yegorov

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
VKVictor P. Kutyshenko
Victor P. Kutyshenko
GMGalina V. Mikoulinskaia
Galina V. Mikoulinskaia
SCSergei V. Chernyshov
Sergei V. Chernyshov
AYAlexander Yegorov
Alexander Yegorov
DPDmitry A. Prokhorov
Dmitry A. Prokhorov
Vladimir N. UverskyVladimir N. Uversky
Vladimir N. Uversky

1 June 2015 in Thermochimica Acta
Verified
Journal Article
Closed access
AYAlexander Yegorov
Alexander Yegorov
SPSergey A. Potekhin
Sergey A. Potekhin

1 December 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
VKVictor P. Kutyshenko
Victor P. Kutyshenko
GMGalina V. Mikoulinskaia
Galina V. Mikoulinskaia
DPDmitry A. Prokhorov
Dmitry A. Prokhorov
NMNikolai V. Molochkov
Nikolai V. Molochkov
AYAlexander Yegorov
Alexander Yegorov
Vladimir N. UverskyVladimir N. Uversky
Vladimir N. Uversky

1 January 2018 in Molecular Biology
Verified
Journal Article
Closed access
PDF file
AYAlexander Yegorov
Alexander Yegorov
SPS. A. Potekhin
S. A. Potekhin
The heat denaturation of lysozyme has been studied by high-pressure differential scanning microcalorimetry. It has been demonstrated that an increase in pressure has different influence on...

29 December 2024 in Polymers
Verified
Journal Article
Open access
PDF file
AYAlexander Yegorov
Alexander Yegorov
SPSergei Pushkin
Sergei Pushkin
EAElena Arshintseva
Elena Arshintseva
MMMaxim Molchanov
Maxim Molchanov
Maria TimchenkoMaria Timchenko
Maria Timchenko
The physicochemical properties of emulsions based on poloxamers (triblock copolymers of a hydrophobic polyoxypropylene chain and two hydrophilic polyoxyethylene chains) depend on the composition and preparation method. This study examined the impact of poloxamer P188 concentration, autoclaving mode, heating, and salt presence on the viscosity, particle size distribution, and morphology of particles using viscometric analysis, dynamic light scattering (DLS), and atomic force microscopy (AFM). It was shown that sample preparation affects the particle size and morphology but not the chemical composition of P188. The most similar properties were found for 10% P188 samples sterilized by filtration and autoclaving. The higher autoclave temperature and additional heating of the 10% P188 samples to 70 °C resulted in the formation of larger particles. For 4% P188 samples with 0.6% NaCl, samples heated at 70 °C for 15 h after sterilization filtration and autoclaving were the most similar and homogeneous. The 4% P188 sample with the higher autoclave temperature and subsequent heating had the lowest viscosity. In contrast to 10% P188, for 4% P188 in the presence of salt, the lack of heating resulted in the formation of large particles. The 4% P188 solutions with NaCl were more stable during storage than those with a higher concentration.

Verified
Journal Article
Open access
PDF file
AKArina Kholina
Arina Kholina
НБНаталья Бороздина
Наталья Бороздина
VPVictor Palikov
Victor Palikov
EMEvgeniy Mikhaylov
Evgeniy Mikhaylov
IKIrina N. Kravchenko
Irina N. Kravchenko
AMArkady Murashev
Arkady Murashev
Poloxamer 188 is a polymer that is used as a carrier and stabilizer of pharmacological agents. It has been demonstrated to enhance red blood cell and hemoglobin levels in healthy animals and in select clinical cases. The objective of this study was to assess the efficacy of Poloxamer 188 in CBA mice when administered repeatedly in the carboplatin-induced myelosuppression model. The mice were administered carboplatin once at a dose of 100 mg/kg, and then Poloxamer 188 was orally administered daily at doses of 10 mg/kg, 100 mg/kg, 500 mg/kg, and 1000 mg/kg for 7 and 21 days. Poloxamer 188 at a dose of 1000 mg/kg was found to bring the level of 2,3-bisphosphoglycerate in red blood cells close to control level (p = 0.1331 for the control group compared to Poloxamer at a dose 1000 mg/kg) already from day 8 of the study and in bone marrow resulted in regulation of genes responsible for hematopoiesis. G-GSF at day 8 and TNFα at day 22 gene expression was significantly decreased by 54% (p = 0.012) and 16% (p = 0.024), respectively, with Poloxamer 188 administration at a dose of 100 mg/kg. Additionally, in the bone marrow, the treatment was seen to exert a positive regulatory effect on the genes responsible for hematopoiesis. These findings are consistent with the observed increase in red blood cell by 6.7% (p = 0.001), hemoglobin by 4.7% (p = 0.0053), and reticulocyte percentage by 53.6% (p < 0.0001) following Poloxamer 188 administration at a dose of 1000 mg/kg in CBA mice with myelosuppression.